Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China flag China · Delayed Price · Currency is CNY
54.76
+0.34 (0.62%)
Apr 29, 2026, 3:00 PM CST

Hangzhou Alltest Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
1,7481,067920.381,3181,9822,179
Upgrade
Trading Asset Securities
488.181,3251,6571,4711,833780.2
Upgrade
Cash & Short-Term Investments
2,2362,3922,5782,7893,8152,960
Upgrade
Cash Growth
-12.23%-7.20%-7.57%-26.89%28.90%322.40%
Upgrade
Accounts Receivable
151.32159.05125.12100.87138.66208.2
Upgrade
Other Receivables
6.385.986.678.1810.3567.4
Upgrade
Receivables
157.7165.03131.79109.05149.02275.6
Upgrade
Inventory
184.96176.69160.32188.59193.66383.84
Upgrade
Prepaid Expenses
--0.7111.652.158.19
Upgrade
Other Current Assets
113.1697.8994.7563.2429.6341.03
Upgrade
Total Current Assets
2,6922,8322,9653,1614,1893,668
Upgrade
Property, Plant & Equipment
1,0241,018903.44759.8317.14223.62
Upgrade
Long-Term Investments
134.58134.58128.6722.9512.254.32
Upgrade
Other Intangible Assets
135.29136.82104.97110.4393.0328.12
Upgrade
Long-Term Deferred Tax Assets
20.1622.0522.230.1846.443.82
Upgrade
Long-Term Deferred Charges
14.9116.4910.3515.7217.885.66
Upgrade
Other Long-Term Assets
87.9783.0551.115.5318.9624.62
Upgrade
Total Assets
4,1094,2424,1864,1164,6954,008
Upgrade
Accounts Payable
79.19120.05104.877.61171.17360.65
Upgrade
Accrued Expenses
11.826.0732.4133.1673.5144.61
Upgrade
Current Portion of Long-Term Debt
0.540.54----
Upgrade
Current Portion of Leases
--2.3416.268.3220.06
Upgrade
Current Income Taxes Payable
77.0483.0686.4373.9673.2661.71
Upgrade
Current Unearned Revenue
33.5835.0240.8441.62147.2226.27
Upgrade
Other Current Liabilities
15.6921.9132.3731.5637.290.91
Upgrade
Total Current Liabilities
217.83286.64299.19274.16510.75714.2
Upgrade
Long-Term Leases
6.816.871.767.6613.4417.3
Upgrade
Long-Term Unearned Revenue
2.142.571.642.68--
Upgrade
Long-Term Deferred Tax Liabilities
--0.01--3.2
Upgrade
Total Liabilities
226.79296.09302.6284.5524.2734.71
Upgrade
Common Stock
79.2879.2879.2879.2853.953.9
Upgrade
Additional Paid-In Capital
1,6831,6801,7081,7131,7441,733
Upgrade
Retained Earnings
2,2222,2022,1772,1072,4551,487
Upgrade
Treasury Stock
-133.31-47.41-113.01-103.4-115.56-
Upgrade
Comprehensive Income & Other
32.4632.1732.530.7528.390.26
Upgrade
Total Common Equity
3,8833,9473,8843,8274,1663,274
Upgrade
Minority Interest
-0.62-0.35-0.224.314.4-
Upgrade
Shareholders' Equity
3,8823,9463,8833,8324,1713,274
Upgrade
Total Liabilities & Equity
4,1094,2424,1864,1164,6954,008
Upgrade
Total Debt
7.357.414.123.9121.7737.36
Upgrade
Net Cash (Debt)
2,2292,3852,5742,7653,7932,922
Upgrade
Net Cash Growth
-12.38%-7.34%-6.92%-27.10%29.80%317.07%
Upgrade
Net Cash Per Share
28.0230.1132.5034.9147.8639.07
Upgrade
Filing Date Shares Outstanding
80.8178.5777.8777.5378.2479.78
Upgrade
Total Common Shares Outstanding
80.8178.5777.8778.1678.2479.78
Upgrade
Working Capital
2,4742,5452,6662,8873,6782,954
Upgrade
Book Value Per Share
48.0550.2349.8748.9753.2541.03
Upgrade
Tangible Book Value
3,7483,8103,7793,7174,0733,246
Upgrade
Tangible Book Value Per Share
46.3848.4948.5347.5652.0640.68
Upgrade
Buildings
--403.78194.44198.8558.13
Upgrade
Machinery
--117.42113.6191.6958.93
Upgrade
Construction In Progress
--459.92488.2542.382.37
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.